Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jay J. Liao, MD"'
Autor:
Marika M. Bierma, BS, BA, Peter H. Goff, MD, PhD, Daniel S. Hippe, MS, Kristina Lachance, MS, Stephanie K. Schaub, MD, Kent Wallner, MD, Yolanda D. Tseng, MD, Jay J. Liao, MD, Smith Apisarnthanarax, MD, Paul Nghiem, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 2, Pp 101364- (2024)
Purpose: The role of postoperative radiation therapy (PORT) in early stage Merkel cell carcinoma (MCC) is controversial. We analyzed the role of PORT in preventing local recurrences (LR) among patients with low-risk, pathologic stage I MCC based on t
Externí odkaz:
https://doaj.org/article/f76692e20b5b4fc791dc49fc6bf08c9d
Autor:
Natalie Viscariello, PhD, Matthew D. Greer, MD, Upendra Parvathaneni, MD, Jay J. Liao, MD, George E. Laramore, MD, PhD, Robert D. Stewart, PhD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 51-61 (2021)
Purpose: Neutron therapy is a high linear energy transfer modality that is useful for the treatment of radioresistant head and neck (H&N) cancers. It has been limited to 3-dimensioanal conformal-based fast-neutron therapy (3DCNT), but recent technica
Externí odkaz:
https://doaj.org/article/101ead0104f24d2691a7cb38e9d3733b
Intensity-Modulated Proton Therapy for Nasopharynx Cancer: 2-year Outcomes from a Single Institution
Autor:
Vonetta M. Williams, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR, George E. Laramore, PhD, MD, Saif Aljabab, MBBS, FRCPC, Tony P. Wong, PhD, Jay J. Liao, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 28-40 (2021)
Purpose: Advances in radiotherapy have improved tumor control and reduced toxicity in the management of nasopharyngeal carcinoma (NPC). Local failure remains a problem for some patients with advanced primary tumors, and toxicities are significant giv
Externí odkaz:
https://doaj.org/article/c2da7a68a072433a94889bddbed5c576
Autor:
Curtis M. Bryant, MD, MPH, Randal H. Henderson, MD, MBA, R. Charles Nichols, MD, William M. Mendenhall, MD, Bradford S. Hoppe, MD, MPH, Carlos E. Vargas, MD, Thomas B. Daniels, MD, C. Richard Choo, MD, Rahul R. Parikh, MD, Huan Giap, MD, PhD, Jerry D. Slater, MD, Neha Vapiwala, MD, William Barrett, MD, Akash Nanda, MD, PhD, Mark V. Mishra, MD, Seungtaek Choi, MD, Jay J. Liao, MD, Nancy P. Mendenhall, MD, the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 1-16 (2021)
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding
Externí odkaz:
https://doaj.org/article/871926a9f47046e99a4987b232eaa487
Autor:
Matthew D. Greer, MD, Stephanie K. Schaub, MD, Stephen R. Bowen, PhD, Jay J. Liao, MD, Kenneth Russell, MD, Jonathan J. Chen, MD, Emily S. Weg, MD, Juergen Meyer, PhD, Tristan Alving, George R. Schade, MD, John L. Gore, MD, Sarah P. Psutka, MD, MS, Robert B. Montgomery, MD, Michael Schweizer, MD, Evan Y. Yu, MD, Petros Grivas, MD, PhD, Jonathan L. Wright, MD, MS, FACS, Jing Zeng, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 2, Pp 100858- (2022)
Purpose: We conducted a prospective pilot study to evaluate safety and feasibility of TraceIT, a resorbable radiopaque hydrogel, to improve image guidance for bladder cancer radiation therapy (RT). Methods and Materials: Patients with muscle invasive
Externí odkaz:
https://doaj.org/article/db65bfdaad0242839436f021308da4cd
Autor:
Seesha R. Takagishi, BS, Tessa E. Marx, BS, Christopher Lewis, BS, Erica S. Tarabadkar, MD, Ilsa D. Juhlin, Astrid Blom, MD, Jayasri G. Iyer, MD, Jay J. Liao, MD, Yolanda D. Tseng, MD MPhil, Teresa Fu, MD, Paul Nghiem, MD PhD, Upendra Parvathaneni, MBBS FRANZCR
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 4, Pp 244-251 (2016)
Purpose: Merkel cell carcinoma (MCC) is a rare and often aggressive skin cancer. Typically, surgery is the primary treatment. Postoperative radiation therapy (PORT) is often recommended to improve local control. It is unclear whether PORT is indicate
Externí odkaz:
https://doaj.org/article/bc63418920f4444db2973fe1ae43ea79